SLC16A1 and breast cancer: The results demonstrated that SLC16A1-AS1 was distributed mostly in the cell cytoplasm than in the nuclear fraction (Figure 4A); consequently, we hypothesized that SLC16A1-AS1 could be a sponge to inhibit miRNAs by binding with their target mRNAs in BC development.